MannKind Corporation has announced that the U.S. Food and Drug Administration (FDA) has accepted its supplemental marketing application for Afrezza, an inhalation powder of human insulin....
GlaxoSmithKline (GSK) announced on Wednesday that the U.S. Food and Drug Administration (FDA) has extended the review period for its blood cancer therapy, Blenrep. This development...
